0000842023-12-000008.txt : 20120214 0000842023-12-000008.hdr.sgml : 20120214 20120214142646 ACCESSION NUMBER: 0000842023-12-000008 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120213 FILED AS OF DATE: 20120214 DATE AS OF CHANGE: 20120214 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ChemoCentryx, Inc. CENTRAL INDEX KEY: 0001340652 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943254365 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 850 MAUDE AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 BUSINESS PHONE: 650-210-2900 MAIL ADDRESS: STREET 1: 850 MAUDE AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TECHNE CORP /MN/ CENTRAL INDEX KEY: 0000842023 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] STATE OF INCORPORATION: MN FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35420 FILM NUMBER: 12607817 BUSINESS ADDRESS: STREET 1: 614 MCKINLEY PL N E CITY: MINNEAPOLIS STATE: MN ZIP: 55413 BUSINESS PHONE: 6123798854 MAIL ADDRESS: STREET 1: 614 MCKINLEY PLACE NE CITY: MINNEAPOLIS STATE: MN ZIP: 55413 4 1 primary_doc.xml PRIMARY DOCUMENT X0304 4 2012-02-13 0 0001340652 ChemoCentryx, Inc. CCXI 0000842023 TECHNE CORP /MN/ 614 MCKINLEY PLACE NE MINNEAPOLIS MN 55413 0 0 1 0 Common Stock 2012-02-13 4 C 0 4713566 A 4713566 D Common Stock 2012-02-13 4 C 0 1021490 A 5735056 D Common Stock 2012-02-13 4 P 0 500000 10 A 6235056 D Series A Preferred Stock 2012-02-13 4 C 0 5000000 D Common Stock 2500000 0 D Series B Preferred Stock 2012-02-13 4 C 0 1946836 D Common Stock 973418 0 D Series C Preferred Stock 2012-02-13 4 C 0 1223148 D Common Stock 611574 0 D Series D Preferred Stock 2012-02-13 4 C 0 1257149 D Common Stock 628574 0 D Convertible Promissory Note 2012-02-13 4 C 0 10214900 D Common Stock 1021490 0 D Warrant 20 2012-02-13 4 A 0 150000 0 A 2012-02-13 2022-02-12 Common Stock 150000 150000 D The Issuer's Preferred Stock, which had no expiration date, automatically converted to Common Stock at the closing of the Issuer's initial public offering ("IPO") on February 13, 2012 at a conversion ratio of one share of Common Stock for every two shares of Preferred Stock rounded down to the next whole number, for no additional consideration. The principal amount of the Convertible Promissory Note, plus accrued interest, automatically converted upon the closing of the IPO at a conversion price of $10.00 per share. Thomas E Oland, CEO 2012-02-14